LISA PROCTOR: Open Payments
NPI 1508521584 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 23 payments from 9 companies in 2025. Trend: 2023 $451 · 2024 $291 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Novo Nordisk Inc | 3 | $60 |
| Inspire Medical Systems, Inc. | 1 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Viatris Specialty LLC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: TRELEGY ELLIPTA, CAPLYTA, Ozempic, INSPIRE, AIRSUPRA, YUPELRI, Qelbree, VRAYLAR.
Industry payments across TX — which companies pay providers there.
